首页> 外文OA文献 >Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
【2h】

Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial

机译:帕尼单抗联合放疗与放化疗联合治疗未切除的局部晚期头颈部鳞状细胞癌(CONCERT-2):一项随机,对照,开放标签的2期试验

摘要

We aimed to compare panitumumab, a fully human monoclonal antibody against EGFR, plus radiotherapy with chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck.
机译:我们的目的是比较未切除的局部晚期头颈部鳞状细胞癌患者panitumumab(一种针对EGFR的完全人类单克隆抗体)加上放疗与化学放射疗法的比较。

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号